experspadmin

Sequencing vs Combination of Novel Molecules in the Treatment of Chronic Lymphocytic Leukemia
Oncology

Sequencing vs Combination of Novel Molecules in the Treatment of Chronic Lymphocytic Leukemia

expert roundtables
By Anthony R. Mato, MD, MSCE; Jennifer R. Brown, MD, PhD
Improving Durability of Response in Patients With High-Risk Chronic Lymphocytic Leukemia
Oncology

Improving Durability of Response in Patients With High-Risk Chronic Lymphocytic Leukemia

expert roundtables
By Anthony R. Mato, MD, MSCE; Jennifer R. Brown, MD, PhD
Preferred Frontline Therapy for Chronic Lymphocytic Leukemia: Patient Preferences Examined
Oncology

Preferred Frontline Therapy for Chronic Lymphocytic Leukemia: Patient Preferences Examined

patient care perspectives
Novel Agents for Chronic Lymphocytic Leukemia: Implications of a Skipped Dose vs Intermittent Dosing
Oncology

Novel Agents for Chronic Lymphocytic Leukemia: Implications of a Skipped Dose vs Intermittent Dosing

patient care perspectives
By Anthony R. Mato, MD, MSCE
Imaging in Chronic Lymphocytic Leukemia: PET/CT for Suspected Richter Transformation
Oncology

Imaging in Chronic Lymphocytic Leukemia: PET/CT for Suspected Richter Transformation

clinical topic updates
By Anthony R. Mato, MD, MSCE
Load More